Berns EM - Search Results

1

Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen.

Ramirez-Ardila DE, Helmijr JC, Look MP, Lurkin I, Ruigrok-Ritstier K, van Laere S, Dirix L, Sweep FC, Span PN, Linn SC, Foekens JA, Sleijfer S, Berns EM, Jansen MP. Ramirez-Ardila DE, et al. Among authors: berns em. Breast Cancer Res Treat. 2013 May;139(1):39-49. doi: 10.1007/s10549-013-2529-7. Epub 2013 Apr 17. Breast Cancer Res Treat. 2013. PMID: 23592373

2

Sporadic amplification of the insulin-like growth factor 1 receptor gene in human breast tumors.

Berns EM, Klijn JG, van Staveren IL, Portengen H, Foekens JA. Berns EM, et al. Cancer Res. 1992 Feb 15;52(4):1036-9. Cancer Res. 1992. PMID: 1310636

3

Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancer.

Berns EM, Klijn JG, Henzen-Logmans SC, Rodenburg CJ, van der Burg ME, Foekens JA. Berns EM, et al. Int J Cancer. 1992 Sep 9;52(2):218-24. doi: 10.1002/ijc.2910520211. Int J Cancer. 1992. PMID: 1325950 Free article.

4

Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors.

Berns EM, Klijn JG, van Staveren IL, Portengen H, Noordegraaf E, Foekens JA. Berns EM, et al. Eur J Cancer. 1992;28(2-3):697-700. doi: 10.1016/s0959-8049(05)80129-7. Eur J Cancer. 1992. PMID: 1350457

5

Prognostic factors in human primary breast cancer: comparison of c-myc and HER2/neu amplification.

Berns EM, Foekens JA, van Putten WL, van Staveren IL, Portengen H, de Koning WC, Klijn JG. Berns EM, et al. J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):13-9. doi: 10.1016/0960-0760(92)90182-i. J Steroid Biochem Mol Biol. 1992. PMID: 1356012

6

Epidermal growth factor receptor in ovarian tumours: correlation of immunohistochemistry with ligand binding assay.

Henzen-Logmans SC, Berns EM, Klijn JG, van der Burg ME, Foekens JA. Henzen-Logmans SC, et al. Among authors: berns em. Br J Cancer. 1992 Dec;66(6):1015-21. doi: 10.1038/bjc.1992.403. Br J Cancer. 1992. PMID: 1457340 Free PMC article.

7

Pleiotropic actions of suramin on the proliferation of human breast-cancer cells in vitro.

Foekens JA, Sieuwerts AM, Stuurman-Smeets EM, Dorssers LC, Berns EM, Klijn JG. Foekens JA, et al. Among authors: berns em. Int J Cancer. 1992 May 28;51(3):439-44. doi: 10.1002/ijc.2910510317. Int J Cancer. 1992. PMID: 1592534 Free article.

8

c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer.

Berns EM, Klijn JG, van Putten WL, van Staveren IL, Portengen H, Foekens JA. Berns EM, et al. Cancer Res. 1992 Mar 1;52(5):1107-13. Cancer Res. 1992. PMID: 1737370

9

Antiproliferative effects of suramin on androgen responsive tumour cells.

Berns EM, Schuurmans AL, Bolt J, Lamb DJ, Foekens JA, Mulder E. Berns EM, et al. Eur J Cancer. 1990 Apr;26(4):470-4. doi: 10.1016/0277-5379(90)90018-o. Eur J Cancer. 1990. PMID: 2141513

10

Infrequent CDKN2 (MTS1/p16) gene alterations in human primary breast cancer.

Berns EM, Klijn JG, Smid M, van Staveren IL, Gruis NA, Foekens JA. Berns EM, et al. Br J Cancer. 1995 Oct;72(4):964-7. doi: 10.1038/bjc.1995.442. Br J Cancer. 1995. PMID: 7547249 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters